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Abstract: Metallic materials, such as Co–Cr–Mo alloys, are exposed to aggres-
sive conditions in the oral cavity that represents an ideal environment for 
metallic ion release and biodegradation. The metallic ions released from dental 
materials can cause local and/or systemic adverse effects in the human body. 
Therefore, dental materials are required to possess appropriate mechanical, 
physical, chemical and biological properties. The biocompatibility of metallic 
materials is very important for dental applications. Accordingly, the aim of this 
study was to examine metallic ion release and cytotoxicity of Co–30Cr–5Mo 
cast alloy as the initial phase of biocompatibility evaluation. Determination of 
the viability of human (MRC-5) and animal (L929) fibroblast cells were 
conducted using three in vitro test methods: the colorimetric methyl-thiazol-
tetrazolium (MTT) test, the dye exclusion test (DET) and the agar diffusion test 
(ADT). Furthermore, the morphology and growth of the cells were analyzed 
using scanning electron microscopy (SEM). The obtained results indicated that 
Co–30Cr–5Mo alloy did not release harmful elements in concentrations high 
enough to have detrimental effects on human and animal fibroblasts under the 
given experimental conditions. Moreover, the fibroblast cells showed good 
adhesion on the surface of the Co–30Cr–5Mo alloy. Therefore, it could be con-
cluded that Co–30Cr–5Mo alloy is a biocompatible material that could be 
safely used in dentistry.  
Keywords: Co-based alloy, biomaterials, cytotoxicity, fibroblasts. 
INTRODUCTION 
The most extensively used metallic materials in dental practice are com-
mercially pure titanium (CPTi), and titanium- and cobalt-based alloys, whilst 
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stainless steels were abandoned primarily due to nickel-induced hypersensitivity 
of the organism.1 CPTi and its alloys are mostly used as endosseous implants, 
while Co–Cr–Mo alloys have been widely applied as subperiosteal implants and 
removable partial denture frameworks due to their outstanding mechanical pro-
perties and high corrosion resistance.2,3 In fact, Co–Cr–Mo alloys have better 
mechanical strength and corrosion resistance compared to stainless steel.4 Chro-
mium, the main alloying element in Co–Cr–Mo alloys, is added to advance the 
formation of a stable passive oxide layer that contributes to corrosion resistance, 
while molybdenum is also frequently added to increase alloy resistance to pitting 
and crevice corrosion. The composition of Cr and Mo in commercial alloys lies 
within the range of 11–25 mass % and the corrosion behaviour of Co–Cr–Mo 
alloys depends primarily on the Cr and Mo levels in the alloy, i.e., alloys with 
lower amounts of Cr and Mo are found to be more susceptible to corrosion.5 
Although the metallic dental materials are considered to have excellent corrosion 
resistance, numerous studies showed that metallic ions could be released into the 
surrounding environment.6,7 The released metallic ions from dental materials 
could diffuse into mucosal tissue or could be distributed throughout the human 
body and cause adverse biological effects, depending on the ion type and concen-
tration.4,8 For instance, Ichinose et al.9 showed that Co–Cr–Mo alloys disin-
tegrate easily in cells, i.e., Co dissolves from the peripheral areas of the cells 
although Cr remains within them. The main factors affecting metallic ion release 
from dental materials are the quantity and quality of the saliva, plaque, pH value, 
temperature and presence of proteins. Additionally, the physical and chemical 
properties of food and liquids as well as oral health conditions have great inf-
luences on ion release.10 Furthermore, the composition and pre-treatment of the 
materials are very important factors that have a significant influence on metallic 
ion release.11,12 Consequently, the contact between Co–Cr–Mo alloys and human 
saliva leads to the release of metallic ions.13,14 It should be emphasized that bio-
corrosion of Co–Cr–Mo alloys is one of the major problems during their appli-
cation as dental materials.4 Many authors reported toxic and carcinogenic effects 
induced when humans and animals are exposed to certain metals.11 Thus, the 
requirements of dental materials are primarily non-toxicity and biocompatibility. 
It should be underlined that biocompatibility of metallic materials is dependent 
on the release of elements from the materials.12 Therefore, the main purpose of 
this study was to examine metallic ion release in artificial saliva and in vitro 
cytotoxicity of Co–30Cr–5Mo alloy. The cytotoxicity of the mentioned alloy was 
assessed using human (MRC-5) and animal (L929) fibroblast cell lines according 
to ISO 10993-5 and ISO 7405 standards, respectively.15,16 The effects of 
Co–30Cr–5Mo cast alloy on cell viability, morphology and spreading on the 
surface were also determined in this study. Determination of cells viability was 
conducted using three in vitro test methods: the colorimetric methyl-thiazol- 
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-tetrazolium (MTT) test, the dye exclusion test (DET) and the agar diffusion test 
(ADT). Although only the ADT assay has been prescribed in ISO 7405 
standard,17 the use of different test methods is highly advisable.18 For the 
purpose of cells morphology and spreading analyses, scanning electron 
microscopy (SEM) was used. It is very important to mention that the increased 
worldwide interest in utilizing Co-based alloys for dental applications is related 
to their low cost and adequate mechanical properties,3 and therefore Co–30Cr–
5Mo alloy was chosen for examination in this study. 
MATERIALS AND METHODS 
Material preparation 
The chemical composition of Co–30Cr–5Mo alloy (Wironit® extra-hard, Bego, Ger-
many) used in this study was (in mass %): Co 63.0, Cr 30.0, Mo 5.0, max. 0.4 C, and trace 
amounts of Si and Mn. The physicochemical properties of the examined alloy were presented 
in a previous study.13 The Co–30Cr–5Mo alloy in the as-cast condition was selected for 
consideration in this study for two reasons: 1) Co-based alloys are most often used in cast or 
cast and annealed metallurgic conditions2 and 2) this type of alloy is widely used in dental 
practice, mostly for the manufacture of crowns, bridges and denture bases,19 regardless of 
some results which indicate that harmful effects were induced by released ions and cells 
damage were caused by Co–Cr–Mo alloys.1,9 The cylindrically-shaped specimens (8.0 mm in 
diameter and 15.8 mm in height) were cut into disc-shaped samples (8.0 mm in diameter and 
4.0 mm in thickness). Subsequently, the samples were ground to 1200 grit with silicon carbide 
(SiC) papers and polished using diamond paste. Thereafter, the samples were cleaned in an 
ultrasonic bath with ethanol for 15 min followed by rinsing with distilled water for 5 min in 
order to eliminate surface impurities.  
Microstructure characterization and hardness determination 
The microstructure characterization of Co–30Cr–5Mo alloy used in this study was real-
ized using a Carl Zeiss Opton Axioplan optical microscope (OM) and a JEOL JSM 5800 
scanning electron microscope (SEM), which was operated at an accelerating voltage of 25 
keV. Before the microscopic analysis, the examined material was etched using a solution 
containing 92mL HCl, 5mL H2SO4 and 3mL HNO3. The Vickers hardness, HV, was mea-
sured on the polished mirror-like surface of the samples using a Buehler Identamet micro-
indentation hardness tester, model 1114, under a load of 2.94 kN for 5 s.  
Metallic ion release  
After standard metallographic preparation of the samples and their ultrasonic cleaning, 
each sample was placed in a separate glass test tube with 5 mL of artificial saliva (Helve-
pharm AG, Switzerland) and thermostated at 37 °C. In order to designate the effect of the pH 
value of the artificial saliva on metallic ion release from Co–30Cr–5Mo alloy, the pH value 
was set to different levels (7.5, 5.5 and 4.0). The concentrations of released metallic ions were 
quantified after 1, 3 and 6 weeks using an Agilent ICP MS 7500ce inductively coupled 
plasma-mass spectrophotometer (ICP-MS). 
Cell lines 
The human (MRC-5) and animal (L929) fibroblast cell lines were grown attached to the 
surface of flasks (Costar, 25 cm3) in Eagle’s medium modified by Dulbecco (DMEM, Gibco 
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BRL, UK) with 4.5 g L-1 glucose and 10 % foetal calf serum, FCS (Sigma). The medium 
contained the antibiotics penicillin 100 IU mL-1 and streptomycin 100 μg mL-1. The cell lines 
were maintained under standard conditions at 37 °C under 5 % CO2 humidified environment 
(Heraeus). The cell lines were transplanted twice weekly, and the logarithmic phase of growth 
between the third and tenth transplantation was used in the assays. The cell number and 
percentage of viable cells were determined by the colour test rejection with 0.1 % trypan blue. 
The viability of cells used in the assays was over 90 %. 
Cell morphology  
For the purpose of the morphological characterization of MRC-5 cells on the surface of 
Co–30Cr–5Mo alloy, the cells were collected during the logarithmic phase of growth, tryp-
sinized, resuspended and counted in 0.1 % trypan blue. Subsequently, the cells (1×105 cells 
mL-1) were seeded directly on the material surface and cultivated at 37 °C under a 5 % CO2 
humidified environment for 48 h. After the incubation period, the MRC-5 cells were photo-
graphed with a Canon 1100D camera attached to an inverted microscope Reichert–Jung Bio-
star 1820 E with 20 and 40× magnification objectives. SEM analysis of MRC-5 cells was 
performed on the same sample using SEM MIRA3 Tescan operated at an accelerating voltage 
of 20 keV. Before the SEM observations, the MRC-5 cells were fixed in 2.5 % glutaraldehyde 
for 48 h and dehydrated using the following solutions: 3 % acetic acid, 3 % acetic acid and 25 % 
ethanol at a ratio 1:1, 3 % acetic acid and 50 % ethanol at a ratio 1:1, and 70 % ethanol. 
Subsequently, the MRC-5 cells were coated with a thin Au–Pd layer using a Baltec SCD 005 
sputter coater. 
In vitro cytotoxicity tests 
The Co–30Cr–5Mo alloy cytotoxicity was measured as the percentage of cell growth 
inhibition using three types of in vitro tests: the colorimetric methyl-thiazol-tetrazolium 
(MTT) test, the dye exclusion test (DET) and the agar diffusion test (ADT), which are briefly 
described in the Supplementary material to this paper.  
RESULTS AND DISCUSSION 
Microstructure characterization and hardness determination 
The OM and SEM micrographs of Co–30Cr–5Mo alloy in as-cast condition 
are shown in Fig. 1. The microstructure of examined material consisted of 
 
Fig. 1. a) OM and b) SEM micrographs showing the microstructure of the Co–30Cr–5Mo 
alloy in as-cast condition. 
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dendrites (dark parts in Fig. 1a; light parts in Fig. 1b) and interdendritic regions 
(light parts in Fig. 1a; dark parts in Fig. 1b). 
Similarly, Xin et al.20 showed that the microstructure of a Co–Cr–Mo alloy 
obtained by traditional casting has a typical dendritic microstructure. Likewise, 
Patel et al.21 described the microstructure of a Co–Cr–Mo alloy in details; the 
microstructure consisted of a solid Co matrix with interdendritic phases and car-
bides. The carbides were a combination of carbon and either Co, Cr or Mo, and 
were denoted as MnCn where M is Co, Cr or Mo. Furthermore, XRD analysis 
performed by the same authors indicated that the Co–Cr–Mo alloy (ASTM F75) 
consisted of face-centred cubic (fcc) Co, M23C6 and a sigma (σ) phase. It should 
be mentioned that the allotropic phase transformation of pure Co from the high 
temperature α phase (fcc) to the low temperature ε phase (hexagonal close-
packed, hcp) occurs at about 420 °C.22,23 Alloying elements, such as Fe and Ni, 
can stabilize the α phase, while Cr and Mo tend to stabilize the ε phase. Further-
more, Saji and Choe22 using EDS analysis showed that the chemical compo-
sitions of the dendrites and interdendritic regions are similar. However, the den-
dritic regions are slightly rich in Cr and poor in Co. The obtained hardness of the 
Co–30Cr–5Mo alloy investigated in this study was 287.6±36.7 HV. According to 
Patel et al.,21 the hardness of a Co–Cr–Mo alloy is correlated with its carbide 
content.  
Metallic ion release  
The metallic ion release testing in artificial saliva was preceded in this study 
by an in vitro cytotoxicity examination. As mentioned earlier, Co–Cr–Mo alloys 
are usually used to fabricate dental prostheses and subperiosteal implants, which 
are in contact with gingiva, and therefore artificial saliva was used as the testing 
solution. The obtained results are shown in Fig. 2.  
As can be seen from the diagrams, the concentrations of released metallic 
ion increased almost linearly with increasing immersion time, a conclusion that 
was also reached by Nejatidanesh et al.24 Furthermore, the metallic ion release 
rate increased with decreasing pH value of the artificial saliva. The most 
pronounced effect of the pH value of the artificial saliva on metallic ion release 
could be observed in the case of Co after 6 weeks of immersion. Similarly, 
Denizoglu et al.25 investigated ion release from a Co-based alloy (alloy 
composition: Co 64.0, Cr 28.65, Mo 5.0, Mn 1.0, Si 1.0, C 0.35) and showed that 
the pH value of the testing solution significantly affected the total and Co ion 
release, but not Cr ion release. The concentrations of the released Cr and Mo did 
not differ drastically, but the weight content of Mo in the Co–Cr–Mo alloy was 
much smaller than that of Cr. Therefore, it could be concluded that the con-
centrations of released metallic ions do not reflect their weight contents in the 
alloy.13,25 Many authors examined the corrosion resistance of Co–Cr–Mo alloys  
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 (a) (b) 
(c) 
Fig. 2. The concentrations of ions released 
from the Co–30Cr–5Mo alloy in artificial 
saliva: a) Co, b) Cr and c) Mo. 
and metallic ion release as a direct consequence of corrosion. For instance, 
Branzoi et al.14 showed that the corrosion resistance of a Co–Cr–Mo alloy was 
higher than in the case of a Co–Cr–Ti alloy because the stability of the passive 
oxide film present on the Co–Cr–Mo surface was higher. Jevremović et al.18 
examined the release of ions from a Co-based alloy fabricated using both trad-
itional casting and selective laser melting (SLM) techniques and concluded that 
the ion release rate was lower in the case of the SLM prepared alloy. Further-
more, Doni et al.26 presented that a Co–Cr–Mo alloy showed a lower tendency to 
corrosion in a NaCl solution under sliding compared to the Ti–6Al–4V alloy. 
Puškar et al.27 examined the behaviour of a Co–Cr–Mo alloy in artificial saliva at 
37 °C for 7 days and concluded that the quantities of released Co, Cr and Mo 
were far below the permitted levels. According to the ISO 22674 standard, the 
quantity of an element released from the alloy should not exceed 200 μg cm–2 
during 7 days.28 In this study, Mo had the highest release rate after 7 days, but 
the amounts of the released ions never exceeded 2 μg cm–2. Thus, the quantities 
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of released ions were 100-fold lower than the permitted quantities. It is important 
to note that Beer-Lech and Surowska29 showed that a Co–Cr–Mo alloy had very 
good passivation ability. Many authors linked metallic ion release with biocom-
patibility of dental materials.24,25,30 It was observed that the concentration of 
released ions from the examined Co-based alloy was significantly higher when 
compared to other Co–Cr–Mo alloys13 and it should therefore provide more 
information about the cytotoxicity potential of this alloy and the possibility of 
using an untreated Co–Cr–Mo cast alloy for dental applications. 
In vitro cytotoxicity tests as the initial phase of biocompatibility examination 
The results of the colorimetric methyl-tiasol-tetrazolium (MTT) and dye 
exclusion test (DET) assays, presented in Fig. 3, showed that the Co–30Cr–5Mo 
alloy did not exhibit cytotoxic effect either in contact with MRC-5 or L929 
fibroblast cells. In fact, the results of the MTT test (Fig. 3a) indicate a gradual 
increase in cell viability with increasing contact time. After 72 h, both MRC-5 
and L929 cells in contact with the Co–30Cr–5Mo alloy showed almost the same 
viability as the cells in the control sample. After 96 h, the cell viability further 
increased, meaning that the Co–30Cr–5Mo alloy did not exhibit toxic effects on 
the cells. The diagram of the DET results (Fig. 3b) shows an enhancement in cell 
viability with increasing contact time. As can be seen, the Co–30Cr–5Mo alloy 
showed excellent cytocompatibility with MRC-5 cells after 96 h, whilst the L-
929 cells in contact with Co–30Cr–5Mo alloy had slightly lower survival rates 
than the MRC-5 cells. These differences, caused by the cell type which was used 
for testing, are negligibly small. Furthermore, since the decolourization index 
was 0 (no decolourization detectable around or under the disc-shaped samples) 
and the lysis index was 0 (no cell lysis detectable), the examined material was 
 
 (a) (b) 
Fig. 3. Fractions of surviving fibroblast cells compared with the respective control (K) in: 
a) the MTT and b) the DET assay. 
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not cytotoxic according to agar diffusion test (ADT). 
These results are in accordance with the observation of Jevremović et al.18 
who demonstrated that an ASTM F75 Co-based alloy obtained by casting and 
SLM did not release harmful elements that could cause acute effects against ani-
mal fibroblast cells (L929). Similarly, Xin et al.20 showed good spreading of 
mouse fibroblasts (3T3) on the surface of a Co-based cast alloy. The advantage 
of present study compared to studies by Jevremović et al.18 and Xin et al.20 is 
that the cytotoxicity of the Co–30Cr–5Mo alloy was examined using both human 
and animal fibroblast cells, because the use of human cells provides more valid 
results and better insight into the behaviour of this alloy in the human body. Dif-
ferent and often contradictory studies regarding cytotoxicity/cytocompatibility of 
Co–Cr–Mo alloys can be found in the literature. On the one hand, Čairović et 
al.31 emphasized that cells adapted to the presence of a Co-based alloy after an 
initial toxic effect. On the other hand, it was shown that CPTi, Ti–Al–V and 
Co–Cr–Mo alloys caused cell damage in direct contact with cells, while in indir-
ect contact, only the Co–Cr–Mo alloy caused cell damage.1 Furthermore, Fleury 
et al.32 demonstrated that Cr3+ (0–150 ppm) and Co2+ (0–10 ppm) ions have a 
cytotoxic effect on oesteoblast-like cells (MG-63). Microscopic analysis demon-
strated changes in the shape, size and number of cells, whereas Co2+ had a 
greater effect on these parameters than Cr3+. Even if there are articles in the lite-
rature that highlighted the cytotoxicity of Cr and Co, the results in this study 
indicated that the Co–30Cr–5Mo alloy did not exhibit cytotoxic effects and these 
results are similar to some published data.18,20,31,33 
Cells morphology and adhesion 
The photograph of MRC-5 cells in culture and in contact with the Co–30Cr– 
–5Mo alloy is shown in Fig. 4. It can be clearly seen that the cells are attached to 
the edge of the disc-shaped sample of the Co–30Cr–5Mo alloy and that cells are 
mutually connected. 
Fig. 4. MRC-5 cells in contact with 
Co–30Cr–5Mo alloy surface. 
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The SEM micrographs of MRC-5 cells on the surface of the Co–30Cr–5Mo 
alloy are presented in Fig. 5. MRC-5 cells can have different shapes: triangle, 
spindle, elongated, oval, and flat34,35 and in this study, the cells were rounded 
(Fig. 5a) and spindle elongated (Fig. 5b). The rounded cells were slightly smaller 
than spindle elongated cells, but they are very well spread on the Co–30Cr–5Mo 
alloy surface. Furthermore, these micrographs revealed the voluminous nature of 
the cells, which indicates that the cells are metabolically active. Excellent cell 
spreading is shown in Fig. 5c, which demonstrates that Co–30Cr–5Mo alloy is 
not harmful to the appearance of MRC-5 cells. It is obvious that the MRC-5 cells 
show good adhesion on the Co–30Cr–5Mo alloy surface, as can be seen in Fig. 
5d, and thus the biocompatibility of the alloy was demonstrated. 
 
Fig. 5. SEM micrographs showing MRC-5 
cells attached to the Co–30Cr–5Mo alloy 
surface: a) round cell, b) elongated cell, c) 
enlarged area from (b) and d) cell adhesion to 
the surface. 
CONCLUSIONS 
On the grounds of realized and presented research, the following conclusions 
were reached: 1) The ion release rate of the Co–30Cr–5Mo alloy was small 
enough, i.e., the quantities of released ions were 100-fold lower than those per-
mitted according to the ISO 22674 standard. 2) The metallic ion release dep-
ended on many factors, such as the pH value of artificial saliva and the immer-
sion time. 3) The results of MTT, DET and ADT assays showed that examined 
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Co–30Cr–5Mo alloy did not exhibit cytotoxic effect either in contact with human 
(MRC-5) or animal (L929) fibroblast cells. 4) The human fibroblasts showed 
excellent adhesion and spreading on the surface of the Co–30Cr–5Mo alloy. 
Furthermore, the voluminous nature of the cells indicated that the cells were 
metabolically active and thus the biocompatibility of the Co–30Cr–5Mo alloy 
was demonstrated.  
Based on this in vitro biocompatibility examination, it could be concluded 
that Co–30Cr–5Mo alloy is a biocompatible material that could safely be used in 
dentistry. 
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И З В О Д  
IN VITRO ПРОЦЕНА БИОКОМПАТИБИЛНОСТИ Co–Cr–Mo ДЕНТАЛНЕ 
ЛИВЕНЕ ЛЕГУРЕ 
ИВАНА ДИМИЋ1, ИВАНА ЦВИЈОВИЋ-АЛАГИЋ2, НАТАША ОБРАДОВИЋ1, ЈЕЛЕНА ПЕТРОВИЋ3, 
СЛАВИША ПУТИЋ3, МАРКО РАКИН3 и БРАНКО БУГАРСКИ3 
1Универзитет у Београду, Иновациони центар Технолошко–металуршког факултета, 2Универзитет у 
Београду, Институт за нуклеарне науке „Винча“ и 3Универзитет у Београду, 
Технолошко–металуршки факултет 
Метални материјали, као што су Co–Cr–Mo легуре, су изложени агресивним усло-
вима у усној дупљи која представља идеалну средину за отпуштање металних јона и 
биоразградњу. Јони отпуштени из денталних материјала могу да изазову локалне и/или 
системске штетне ефекте у људском организму. Због тога се захтева да дентални мате-
ријали поседују одговарајућа механичка, физичка, хемијска и биолошка својства. Био-
компатибилност металних материјала је веома битна за денталну примену. Према томе, 
циљ рада је био да се одреди отпуштање јона и цитотоксичност Co–30Cr–5Mo ливене 
легуре, као почетна фаза процене биокомпатибилности. Одређивање вијабилности људ-
ских (MRC-5) и животињских (L929) ћелија фибробласта је спроведено применом три 
теста: колориметријског МТТ теста, теста губљења боје (DET) и агар дифузионог теста 
(ADT). Осим тога, морфологија и раст ћелија су анализирани коришћењем скенирајуће 
електронске микроскопије (SEM). Добијени резултати указују на то да Co–30Cr–5Mo 
легура не отпушта штетне елементе у високим концентрацијама које би могле да проуз-
рокују штетне ефекте на људским и животињским фибробластима под датим експери-
менталним условима. Осим тога, ћелије фибробласта показују веома добру адхезију на 
површини Co–30Cr–5Mo легуре. Према томе, може се закључити да је Co–30Cr–5Mo 
легура биокомпатибилни материјал који се безбедно може користити у стоматологији. 
(Примљено 5. маја, ревидирано 13. августа, прихваћено 26. августа 2015) 
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